Successor liability around regulatory compliance can derail otherwise great deals and create major post-acquisition headaches that can undermine the value of a business. Heightened geopolitical, technological, and trade tensions with China, combined with a tighter U.S. regulatory environment around export controls and trade sanctions, have dramatically increased successor liability risks. The potential impact on a deal cuts right to a company’s core business, posing far greater risks than before, and the trends on the horizon only exacerbate the issues. Avoiding these new emerging potential landmines will be critical to a deal’s success.
This panel of experts will discuss these issues and what companies, venture capital and private equity sponsors, and dealmakers can do to address them.
Join our panel of leading experts who will discuss insights into critical questions including:
● Have China and the U.S. indeed entered into a new “Cold War II”? What does this mean and how will it play out? How will this impact businesses and deal-making?
● What makes trade compliance issues especially risky in the new emerging environment? What is driving the regulatory and enforcement activity? How can these potentially slash valuations and even derail a deal?
● What can deal-makers do to avoid the increasing landmines and pitfalls all these issues may bring?
Please fill out the form to watch the video replay of the webcast on demand.
A series of discussions for healthcare dealmakers on the current opportunities, pitfalls and latest developments in the M&A market.
Experts discuss trends in the tech M&A market including virtual dealmaking, the proliferation of SPACs, stock sell-off and cross border deals.